Ulcerative colitis (UC) is an inflammatory bowel disease of unknown aetiology. In this study, serum samples from 80 patients with UC were studied for the presence of various autoantibodies and soluble interleukin-2 receptor molecules (sIL-2Rs) in an attempt to determine the degree of activation of the immune system in this disease process. Autoantibodies detected included rheumatoid factors (in 5% of patients), antinuclear antibodies (in 51-3%), (ESR, p=0O0001). Platelets, ESR, and C3c were not associated with disease activity (p=0-06, 0-33 and 0.86) whereas mean (SD) serum concentrations of C4 were higher in active disease (37.4 (11.9) mg/dl v 32-3 (10-3) mg/dl, p<0-05).
anti-Ro(SSA) (in 1.3%), anticardiolipin antibodies (IgG and/or IgM classes in 26-3%), anti-double stranded DNA (IgG or IgM classes in 45%), and antineutrophil cytoplasmic antibodies (ANCAs, in 30%). The ANCAs had a perinuclear pattern (p-ANCA) in 95-8%, without antimyeloperoxidase activity, at least in an enzyme linked immunosorbent assay (ELISA) system. Raised concentrations of sIL-2R were found in 32-5% ofpatients (26/80, 18 with active and eight with inactive UC). The mean (SD) sIL-2R concentrations were significantly higher in patients with active UC (595 (219) u/ml v 406 (162) u/ml, p = 0-0001) and in patients with ANCAs (584 (177) u/ml in ANCA positive v 447 (212) u/ml in ANCA negative patients, p<0-01). The sIL-2R concentrations were correlated with increased serum concentrations of C3c (r=0.23, p<0.05) or C4 (r=0. 4, p<0001) components of the complement system and erythrocyte sedimentation rate (ESR, r=0-44, p=0O0001). Platelets, ESR, and C3c were not associated with disease activity (p=0-06, 0-33 and 0.86) whereas mean (SD) serum concentrations of C4 were higher in active disease (37.4 (11.9) mg/dl v 32-3 (10-3) mg/dl, p<0-05).
The sIL-2Rs had 53% sensitivity and 82-6% specificity for disease activity whereas platelet counts had 53% sensitivity and 58-7% specificity. To conclude, UC is accompanied by an autoimmune response that results in the production of several autoantibodies and cellular immune activation, as shown by the high sIL-2R concentration, is also present. The identification of the target antigen(s) of p-ANCA would possibly act as an indicator of disease activity ifthis distinct subset ofANCAs can be attributed to the pathogenesis of UC. The sIL-2R concentrations seem to be a useful laboratory marker for assessing activity of (Table III) . Moreover, the mean concentrations of C3c and C4 in paired serum samples form 10 patients during active disease and after a clinical remission confirmed this association (Fig 1) . (Table III) , anatomical extent (X2=1V23, p=0 54 and X2=1X38, p=050), severity (X2=O025, p=0-88 and X2=4-8, p=009), the duration of the disease (unpaired t test, p=0 ¶97 and p=0 10), or the current immunosuppressive treatment of the patients (X'=0-08, p=0 77 and x'=1-68, p=020). These autoantibodies mainly represent an IgM response (66-7% of anti-CL and 77-8% of anti-dsDNA positive patients). The binding index in patients positive for anti-CL antibodies was 133 (27) (IgG, n=8) and 147 (25) (IgM, n= 14) whereas for anti-dsDNA antibodies the binding index was 162 (17) (IgG, n=9) and 172 (55) (IgM, n=28). In general, however, the binding index for these autoantibodies in UC patients did not differ statistically from the binding index of healthy controls. Moreover, no association was found between anti-CL and antidsDNA antibodies and C3c and C4 components of the complement system and the haematological variables studied (Table IV) . None of the anti-CL positive patients had any manifestations of the so called antiphospholipid syndrome (thrombosis, thrombocytopenia, and recurrent fetal loss)."819 ANCAs were found in 30% of patients (mean titre 1:48, range 1:20-1:160). The detectable ANCAs had a perinuclear pattern in 95 *8% of patients and one patient had a mixed pattern (perinuclear and diffuse cytoplasmic). With the ELISA technique, anti-MPO antibodies were not found in any of the patients. The ANCAs could not be associated with the activity (Table III) (Table IV) . SOLUBLE 
INTERLEUKIN-2 RECEPTORS
The mean (SD) sIL-2R concentrations (U/ml) in the serum samples from 34 patients with active UC (598 (219)) were significantly higher (p=00001, Table III, Fig 2) than in the 46 patients with inactive disease (406 (162)), and both subgroups had significantly higher concentrations (active, p<00005 and inactive, p<0001) than healthy controls (309 (83)). Raised concentrations of sIL-2Rs (higher than the cut off point, 550 U/ml) were found in 32-5% (26/80, 18 with active and eight with inactive UC) of patients, in association with disease activity (x2=9 7, p<0 01). Also, paired serum samples from 10 patients during active disease and after a clinical remission were also evaluated. We found significantly higher sIL-2R concentrations (Fig 3) patient population (574 (137) U/ml than after a clinical remission (297 (100) U/ml p<0-001). The mean sIL-2R concentrations were associated with the presence of ANCAs (Fig 2) as well as with the presence ofat least one specific autoantibody (Fig 2) . By contrast, sIL-2R was not associated with the extent (ANOVA, p=0 38), severity (ANOVA, p=0 28), the duration of the disease (regression analysis, p=0 97), or age and sex (data not shown). A positive correlation was found between the concentrations of sIL-2R and C3c and C4 concentrations (Figs 4 and 5) . Concentrations of sIL-2Rs were positively correlated with ESR (Fig 6) but ESR was not associated with activity of disease (p=0-33; Table III) . No correlation was found between sIL-2R concentrations and the other haematological variables studied (data not shown) or the current immunosuppressive treatment of the patients (unpaired t test, p=0 37).
Increased concentrations of sIL-2R (550 U/ml) were found in 18 patients with active disease (sensitivity 53%) whereas decreased concentrations of sIL-2R were found in 38 patients with inactive disease (specificity 82-6%). By contrast, platelet counts were 53% sensitive and 3' In conclusion, we suggest that UC is accompanied by an autoimmune response, as shown by the presence of low titres of various non-organ specific autoantibodies and cellular immune activation (indicated by high sIL-2R concentrations). The detection of the distinct subset p-ANCAs is of interest as it has been found mainly in UC and in conditions such as primary sclerosing cholangitis that may accompany UC. The identification of the target antigen(s) of p-ANCA would possibly clarify the specificity of this distinct subset of ANCAs for UC. Until this identification is established, the high specificity of sIL-2R for UC activity seems to be the best laboratory indicator for assessing activity of UC. 
